Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy

Blood (2019) 133 (6): 550–565.

https://doi.org/10.1182/blood-2018-07-866830

Published: 2019

Includes: Supplemental data

Journal Articles

Analysis of the Multiple Myeloma HLA Peptidome Identifies a Naturally Presented Bcma-Derived Peptide As an Immunogenic T-Cell Epitope for Immunotherapeutic Approaches

Tatjana Bilich, Simon D. Walz, Annika Nelde, Helmut R. Salih, MD, Ana Marcu, Daniel Johannes Kowalewski, Katja Weisel, MD, Lothar Kanz, Hans-Georg Rammensee, Stefan Stevanovic, Juliane S. Walz

Blood (2018) 132 (Supplement 1): 3173.

https://doi.org/10.1182/blood-2018-99-113473

Published: 2018

Journal Articles

Mass Spectrometry-Based Immunopeptidome Analysis of Acute Myeloid Leukemia Cells Under Decitabine Treatment Delineates Induced Presentation of Cancer/Testis Antigens on HLA Class I Molecules

Jens Bauer, Nora Zieger, Annika Nelde, Leon Bichmann, Helmut R. Salih, MD, Lothar Kanz, Hans-Georg Rammensee, Stefan Stevanovic, Juliane S. Walz

Blood (2018) 132 (Supplement 1): 5223.

https://doi.org/10.1182/blood-2018-99-113357

Published: 2018

Journal Articles

The HLA Ligandome Landscape of Chronic Myeloid Leukemia Delineates Novel T-Cell Epitopes for Immunotherapy

Blood (2018) 132 (Supplement 1): 4243.

https://doi.org/10.1182/blood-2018-99-113376

Published: 2018

Journal Articles

Radiofrequency Ablation of Liver Metastases from Colorectal Cancer Induces a Cancer-Specific T Cell Repertoire in Humans

Blood (2018) 132 (Supplement 1): 1120.

https://doi.org/10.1182/blood-2018-99-120381

Published: 2018

Journal Articles

Favorable Immune Signature in CLL Patients, Defined By Antigen-Specific T-Cell Responses, Might Prevent Second Skin Cancers

Annika Nelde, Daniel Johannes Kowalewski, Linus Backert, Lothar Kanz, Helmut R. Salih, MD, Hans-Georg Rammensee, Stefan Stevanovic, Juliane Sarah Walz

Blood (2017) 130 (Supplement 1): 5329.

https://doi.org/10.1182/blood.V130.Suppl_1.5329.5329

Published: 2017

Journal Articles

Definition and Characterization of a Peptide Warehouse for the Patient-Individualized Peptide Vaccination Study (iVAC-L-CLL01) after First Line Therapy of CLL

Tatjana Bilich, Annika Nelde, Daniel Johannes Kowalewski, Lothar Kanz, Hans-Georg Rammensee, Stefan Stevanovic, Helmut R. Salih, MD, Juliane Sarah Walz

Blood (2017) 130 (Supplement 1): 5346.

https://doi.org/10.1182/blood.V130.Suppl_1.5346.5346

Published: 2017

Journal Articles

Thermal Ablation of Colorectal Cancer Metastases Leads to Activation of Individual Cancer-Specific T Cell Immunity

Sebastian Haen, MD, Bianca Nussbaum, Daniel Johannes Kowalewski, Guenter Jaeger, Philippe Pereira, Stephan Clasen, Bence Sipos, Ingmar Koenigsrainer, Stefan Beckert, Silvia Wagner, Olaf H. Riess, Alfred Koenigsrainer, Stefan Stevanovic, Lothar Kanz, Hans-Georg Rammensee, Markus W. Loeffler, Cecile Gouttefangeas

Blood (2017) 130 (Supplement 1): 2282.

https://doi.org/10.1182/blood.V130.Suppl_1.2282.2282

Published: 2017

Journal Articles

Mapping the HLA Ligandome Landscape of Chronic Myeloid Leukemia Identifies Novel CD8 + and CD4 + T Cell-Epitopes for Immunotherapeutic Approaches

Tatjana Bilich, Annika Nelde, Daniel J. Kowalewski, Janet Peper, Mirle Schemionek, PhD, Lothar Kanz, MD, Helmut R. Salih, MD, Tim H. Brümmendorf, MD, Vladan Vucinic, MD, Dietger Niederwieser, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2016) 128 (22): 4232.

https://doi.org/10.1182/blood.V128.22.4232.4232

Published: 2016

Journal Articles

Identification of Naturally Presented HLA Ligands of Enriched Leukemic Progenitor Cells for Peptide-Based Immunotherapy in Acute Myeloid Leukemia (AML)

Annika Nelde, Heiko Schuster, Daniel J. Kowalewski, Lothar Kanz, MD, Helmut R. Salih, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2016) 128 (22): 4046.

https://doi.org/10.1182/blood.V128.22.4046.4046

Published: 2016

Journal Articles

HLA Ligandome Analysis of Different Hematological Malignancies Identifies a Small Panel of "Pan-Leukemia"-Associated Antigens

Linus Backert, Daniel J. Kowalewski, Simon D. Walz, Heiko Schuster, Claudia Berlin, Mirle Schemionek, PhD, Tim H. Brümmendorf, MD, Vladan Vucinic, MD, Dietger Niederwieser, MD, Lothar Kanz, MD, Helmut R. Salih, MD, Katja Weisel, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2016) 128 (22): 2169.

https://doi.org/10.1182/blood.V128.22.2169.2169

Published: 2016

Journal Articles

Unique Alterations in the Immunopeptidome of Colorectal Cancer Reflect Specific Transformations in Cancer-Associated Signaling Pathways and Reveal Tumor-Specific HLA-Ligand Modulations

Sebastian P. Haen, MD, Daniel J. Kowalewski, Joerg Bernhardt, Linus Backert, Daniel Backes, Florian Dengler, Stefan Beckert, Ingmar Koenigsrainer, Hans-Georg Kopp, MD, Oliver Kohlbacher, Alfred Koenigsrainer, MD, Lothar Kanz, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Markus W. Loeffler, MD

Blood (2016) 128 (22): 862.

https://doi.org/10.1182/blood.V128.22.862.862

Published: 2016

Journal Articles

HLA Ligandome Analysis of Primary Chronic Lymphocytic Leukemia (CLL) Cells Under In Vitro Lenalidomide Treatment Confirms Lenalidomide as a Suitable Combination Partner for T-Cell Based Immunotherapy

Annika Nelde, Daniel J. Kowalewski, Linus Backert, Heiko Schuster, Lothar Kanz, MD, Helmut R. Salih, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2016) 128 (22): 3234.

https://doi.org/10.1182/blood.V128.22.3234.3234

Published: 2016

Journal Articles

ROR1 Specific T Cell Clones from Healthy Individuals Show Common T Cell Receptor Motifs

Falk Heidenreich, PhD, Elke Ruecker-Braun, PhD, Juliane S. Stickel, MD, Anne Eugster, PhD, Denise Kühn, BSc, Sevina Dietz, Annika Nelde, Antje Tunger, MSc, Rebekka Wehner, PhD, Jan Moritz Middeke, MD, Cornelia S Link, MD, Friedrich Stölzel, MD, Stefan Stevanovic, PhD, Ezio Bonifacio, PhD, Martin Bornhäuser, MD, Gerhard Ehninger, MD, Marc Schmitz, PhD, Johannes Schetelig, MD MSc

Blood (2016) 128 (22): 3364.

https://doi.org/10.1182/blood.V128.22.3364.3364

Published: 2016

Journal Articles

Transcutaneous Immunization with a Solid Nanoscopic Imiquimod Suspension Enhances Tumor Rejection

Pamela Stein, PhD, Karsten Gogoll, PhD, Tanja Peters, PhD, Mark Denny, Stefan Tenzer, PhD, Stefan Stevanovic, PhD, Hansjoerg Schild, PhD Prof., Matthias Theobald, MD PhD, Peter Langguth, Markus Radsak, MD

Blood (2015) 126 (23): 2224.

https://doi.org/10.1182/blood.V126.23.2224.2224

Published: 2015

Journal Articles

Interplay Between the Immune System and Colorectal Carcinoma - Towards Tumor-Specific Peptide-Based Vaccination for Any HLA-Type

Sebastian P. Haen, MD, Daniel Johannes Kowalewski, Stefan Stevanovic, PhD, Linus Backert, Florian Dengler, Daniel Backes, Stefan Beckert, Wagner Silvia, Ingmar Koenigsrainer, Hans-Georg Kopp, MD, Oliver Kohlbacher, Alfred Koenigsrainer, MD, Lothar Kanz, MD, Hans-Georg Rammensee, PhD, Markus W. Loeffler, MD

Blood (2015) 126 (23): 1027.

https://doi.org/10.1182/blood.V126.23.1027.1027

Published: 2015

Journal Articles

Mapping the Impact of Proteasome Inhibitor Therapy on the Immunopeptidome of Multiple Myeloma: Mass Spectrometry Identifies Robust Targets for T Cell Immunotherapy

Daniel Johannes Kowalewski, Simon D. Walz, Linus Backert, Heiko Schuster, Susanne M. Rittig, MD, Katja C. Weisel, Helmut R Salih, MD, Lothar Kanz, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S Stickel, MD

Blood (2015) 126 (23): 3001.

https://doi.org/10.1182/blood.V126.23.3001.3001

Published: 2015

Journal Articles

Identification and Characterization of HLA Class I-Restricted MYD88 L265P-Derived Peptides As Tumor-Specific Targets for Immunotherapy

Annika Nelde, Juliane S Stickel, MD, Daniel Johannes Kowalewski, Oliver Olaf Wolz, Lothar Kanz, MD, Anton W. Langerak, Alice F. Muggen, Irina Bonzheim, Falko Fend, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Alexander N.R. Weber

Blood (2015) 126 (23): 2750.

https://doi.org/10.1182/blood.V126.23.2750.2750

Published: 2015

Journal Articles

Favorable Immune Signature in CLL Patients, Defined By Antigen-Specific T-Cell Responses, Might Prevent Secondary Skin Cancers

Juliane S Stickel, MD, Daniel Johannes Kowalewski, Heiko Schuster, Stefan Kahn, Linus Backert, Lothar Kanz, MD, Helmut R Salih, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD

Blood (2015) 126 (23): 1722.

https://doi.org/10.1182/blood.V126.23.1722.1722

Published: 2015

Journal Articles

The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell–based immunotherapy

Simon Walz, Juliane S. Stickel, Daniel Johannes Kowalewski, Heiko Schuster, Katja Weisel, Linus Backert, Stefan Kahn, Annika Nelde, Tatjana Stroh, Martin Handel, Oliver Kohlbacher, Lothar Kanz, Helmut Rainer Salih, Hans-Georg Rammensee, Stefan Stevanović

Blood (2015) 126 (10): 1203–1213.

https://doi.org/10.1182/blood-2015-04-640532

Published: 2015

Includes: Supplemental data

NARROW

The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy

Analysis of the Multiple Myeloma HLA Peptidome Identifies a Naturally Presented Bcma-Derived Peptide As an Immunogenic T-Cell Epitope for Immunotherapeutic Approaches

Mass Spectrometry-Based Immunopeptidome Analysis of Acute Myeloid Leukemia Cells Under Decitabine Treatment Delineates Induced Presentation of Cancer/Testis Antigens on HLA Class I Molecules

The HLA Ligandome Landscape of Chronic Myeloid Leukemia Delineates Novel T-Cell Epitopes for Immunotherapy

Radiofrequency Ablation of Liver Metastases from Colorectal Cancer Induces a Cancer-Specific T Cell Repertoire in Humans

Favorable Immune Signature in CLL Patients, Defined By Antigen-Specific T-Cell Responses, Might Prevent Second Skin Cancers

Definition and Characterization of a Peptide Warehouse for the Patient-Individualized Peptide Vaccination Study (iVAC-L-CLL01) after First Line Therapy of CLL

Thermal Ablation of Colorectal Cancer Metastases Leads to Activation of Individual Cancer-Specific T Cell Immunity

Mapping the HLA Ligandome Landscape of Chronic Myeloid Leukemia Identifies Novel CD8 + and CD4 + T Cell-Epitopes for Immunotherapeutic Approaches

Identification of Naturally Presented HLA Ligands of Enriched Leukemic Progenitor Cells for Peptide-Based Immunotherapy in Acute Myeloid Leukemia (AML)

HLA Ligandome Analysis of Different Hematological Malignancies Identifies a Small Panel of "Pan-Leukemia"-Associated Antigens

Unique Alterations in the Immunopeptidome of Colorectal Cancer Reflect Specific Transformations in Cancer-Associated Signaling Pathways and Reveal Tumor-Specific HLA-Ligand Modulations

HLA Ligandome Analysis of Primary Chronic Lymphocytic Leukemia (CLL) Cells Under In Vitro Lenalidomide Treatment Confirms Lenalidomide as a Suitable Combination Partner for T-Cell Based Immunotherapy

ROR1 Specific T Cell Clones from Healthy Individuals Show Common T Cell Receptor Motifs

Transcutaneous Immunization with a Solid Nanoscopic Imiquimod Suspension Enhances Tumor Rejection

Interplay Between the Immune System and Colorectal Carcinoma - Towards Tumor-Specific Peptide-Based Vaccination for Any HLA-Type

Mapping the Impact of Proteasome Inhibitor Therapy on the Immunopeptidome of Multiple Myeloma: Mass Spectrometry Identifies Robust Targets for T Cell Immunotherapy

Identification and Characterization of HLA Class I-Restricted MYD88 L265P-Derived Peptides As Tumor-Specific Targets for Immunotherapy

Favorable Immune Signature in CLL Patients, Defined By Antigen-Specific T-Cell Responses, Might Prevent Secondary Skin Cancers

The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell–based immunotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only